v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 48,686 $ 26,251 $ 83,214 $ 53,254
General and administrative 13,557 8,869 26,025 16,206
Total operating expenses 62,243 35,120 109,239 69,460
Loss from operations (61,482) (34,927) (108,015) (68,104)
Other income/(expense):        
Interest and investment income 11,542 3,403 17,807 7,194
Gain/(loss) on investment in former related party 105 32 (197) 27
Loss on currency exchange, net (10) (30) (25) (52)
Other expense (370) (107) (619) (205)
Total other income 11,267 3,298 16,966 6,964
Net loss $ (50,215) $ (31,629) $ (91,049) $ (61,140)
Net loss per share attributable to common stockholders, basic $ (0.9) $ (0.88) $ (1.75) $ (1.71)
Net loss per share attributable to common stockholders, diluted $ (0.9) $ (0.88) $ (1.75) $ (1.71)
Weighted-average number of shares of common stock outstanding including shares issuable under equity-classified pre-funded warrants, used in computing net loss per share of common stock, basic 56,029,124 35,822,308 52,053,022 35,806,591
Weighted-average number of shares of common stock outstanding including shares issuable under equity-classified pre-funded warrants, used in computing net loss per share of common stock, diluted 56,029,124 35,822,308 52,053,022 35,806,591
Comprehensive loss:        
Net Income (Loss) $ (50,215) $ (31,629) $ (91,049) $ (61,140)
Other comprehensive loss:        
Unrealized loss on marketable securities (1,553) (172) (2,617) (8)
Total other comprehensive loss (1,553) (172) (2,617) (8)
Total comprehensive loss (51,768) (31,801) (93,666) (61,148)
License [Member]        
Revenues:        
Revenues $ 761 $ 193 $ 1,224 $ 1,356